Related references
Note: Only part of the references are listed.Central Nervous System Penetration of Antiretroviral Drugs: Pharmacokinetic, Pharmacodynamic and Pharmacogenomic Considerations
Eric H. Decloedt et al.
CLINICAL PHARMACOKINETICS (2015)
Efavirenz alters mitochondrial respiratory function in cultured neuron and glial cell lines
Haryes A. Funes et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Tissue-type plasminogen activator triggers the synaptic vesicle cycle in cerebral cortical neurons
Fang Wu et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2015)
Interferon-α Induces Neurotoxicity Through Activation of the Type I Receptor and the GluN2A Subunit of the NMDA Receptor
Cari F. Kessing et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2015)
Neuronal Bioenergetics and Acute Mitochondrial Dysfunction: A Clue to Understanding the Central Nervous System Side Effects of Efavirenz
Haryes A. Funes et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Combined antiretroviral therapy reduces brain viral load and pathological features of HIV encephalitis in a mouse model
Rajeth Koneru et al.
JOURNAL OF NEUROVIROLOGY (2014)
Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system
Cagla Akay et al.
JOURNAL OF NEUROVIROLOGY (2014)
The relationship of CPE to HIV dementia Slain by an ugly fact?
Joseph R. Berger et al.
NEUROLOGY (2014)
The brain and HAART: collaborative and combative connections
Rick B. Meeker et al.
CURRENT OPINION IN HIV AND AIDS (2014)
A Review of the Toxicity of HIV Medications
Asa M. Margolis et al.
JOURNAL OF MEDICAL TOXICOLOGY (2014)
Neuropsychometric correlates of efavirenz pharmacokinetics and pharmacogenetics following a single oral dose
Daniel H. Johnson et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Antiretroviral neurotoxicity
Kevin Robertson et al.
JOURNAL OF NEUROVIROLOGY (2012)
Intrinsic excitability of CA1 pyramidal neurones from the rat dorsal and ventral hippocampus
Kelly A. Dougherty et al.
JOURNAL OF PHYSIOLOGY-LONDON (2012)
Neurotoxicity of Human Immunodeficiency Virus-1: Viral Proteins and Axonal Transport
Italo Mocchetti et al.
NEUROTOXICITY RESEARCH (2012)
Dendritic Spine Injury Induced by the 8-Hydroxy Metabolite of Efavirenz
Luis B. Tovar-y-Romo et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Successful aging and the epidemiology of HIV
David E. Vance et al.
CLINICAL INTERVENTIONS IN AGING (2011)
Enhanced oxidative stress and increased mitochondrial mass during Efavirenz-induced apoptosis in human hepatic cells
N. Apostolova et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
CH05-10, a novel indinavir analog, is a broad-spectrum antitumor agent that induces cell cycle arrest, apoptosis, endoplasmic reticulum stress and autophagy
Jianlan You et al.
CANCER SCIENCE (2010)
HIV Protease Inhibitors Induce Endoplasmic Reticulum Stress and Disrupt Barrier Integrity in Intestinal Epithelial Cells
Xudong Wu et al.
GASTROENTEROLOGY (2010)
Inhibition of Mitochondrial Function by Efavirenz Increases Lipid Content in Hepatic Cells
Ana Blas-Garcia et al.
HEPATOLOGY (2010)
Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort
K. R. Robertson et al.
NEUROLOGY (2010)
Synaptogenesis in Purified Cortical Subplate Neurons
Claire E. McKellar et al.
CEREBRAL CORTEX (2009)
Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy
L. A. Cysique et al.
NEUROLOGY (2009)
Human Immunodeficiency Virus Protease Inhibitors and Risk for Peripheral Neuropathy
Ronald J. Ellis et al.
ANNALS OF NEUROLOGY (2008)
HIV-Associated Neurocognitive Disorders and the Impact of Combination Antiretroviral Therapies
Beau M. Ances et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2008)
Highly active antiretroviral therapy of cognitive dysfunction and neuronal abnormalities in SCID mice with HIV encephalitis
Jennifer Cook-Easterwood et al.
EXPERIMENTAL NEUROLOGY (2007)
Meeting practical challenges of a trial involving a multitude of treatment regimens: An example of a multi-center randomized controlled clinical trial in neuroAIDS
Susanne May et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2007)
Infection of human immunodeficiency virus and intracellular viral tat protein exert a pro-survival effect in a human microglial cell line
Pauline Chugh et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Sensory neuropathy in human immunodeficiency virus/acquired immunodeficiency syndrome patients: Protease inhibitor-mediated neurotoxicity
JA Pettersen et al.
ANNALS OF NEUROLOGY (2006)
Culturing hippocampal neurons
Stefanie Kaech et al.
NATURE PROTOCOLS (2006)
Highly active antiretroviral therapy and human immunodeficiency virus encephalitis
JE Cook et al.
ANNALS OF NEUROLOGY (2005)
Variations on an inhibitory theme:: Phasic and tonic activation of GABAA receptors
M Farrant et al.
NATURE REVIEWS NEUROSCIENCE (2005)
Practical guidelines to interpret plasma concentrations of antiretroviral drugs
BS Kappelhoff et al.
CLINICAL PHARMACOKINETICS (2004)
Share Paper
